Open AccessS285: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): 2‐YEAR FOLLOW‐UP FROM THE CARDINAL STUDY
Author(s) -
Röth A.,
Barcellini W.,
D'Sa S.,
Miyakawa Y.,
Broome C. M.,
Michel M.,
Kuter D. J.,
Jilma B.,
Tvedt T. H. A.,
Weitz I. C.,
Sourdille T.,
Wang J.,
Vagge D. S.,
Kralova K.,
Shafer F.,
Wardecki M.,
Lee M.,
Berentsen S.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000844032.88465.0b
Subject(s) - medicine , autoimmune hemolytic anemia , adverse effect , interim analysis , clinical endpoint , dosing , quality of life (healthcare) , anemia , hemolysis , gastroenterology , immunology , clinical trial , nursing